Literature DB >> 18445062

Value of real time three-dimensional echocardiography in patients with hypertrophic cardiomyopathy: comparison with two-dimensional echocardiography and magnetic resonance imaging.

Letícia S Bicudo1, Jeane M Tsutsui, Afonso Shiozaki, Carlos E Rochitte, Edmundo Arteaga, Charles Mady, José A F Ramires, Wilson Mathias.   

Abstract

UNLABELLED: Real time three-dimensional echocardiography (RT3DE) has been demonstrated to be an accurate technique to quantify left ventricular (LV) volumes and function in different patient populations. We sought to determine the value of RT3DE for evaluating patients with hypertrophic cardiomyopathy (HCM), in comparison with cardiac magnetic resonance imaging (MRI).
METHODS: We studied 20 consecutive patients with HCM who underwent two-dimensional echocardiography (2DE), RT3DE, and MRI. Parameters analyzed by echocardiography and MRI included: wall thickness, LV volumes, ejection fraction (LVEF), mass, geometric index, and dyssynchrony index. Statistical analysis was performed by Lin agreement coefficient, Pearson linear correlation and Bland-Altman model.
RESULTS: There was excellent agreement between 2DE and RT3DE (Rc = 0.92), 2DE and MRI (Rc = 0.85), and RT3DE and MRI (Rc = 0.90) for linear measurements. Agreement indexes for LV end-diastolic and end-systolic volumes were Rc = 0.91 and Rc = 0.91 between 2DE and RT3DE, Rc = 0.94 and Rc = 0.95 between RT3DE and MRI, and Rc = 0.89 and Rc = 0.88 between 2DE and MRI, respectively. Satisfactory agreement was observed between 2DE and RT3DE (Rc = 0.75), RT3DE and MRI (Rc = 0.83), and 2DE and MRI (Rc = 0.73) for determining LVEF, with a mild underestimation of LVEF by 2DE, and smaller variability between RT3DE and MRI. Regarding LV mass, excellent agreement was observed between RT3DE and MRI (Rc = 0.96), with bias of-6.3 g (limits of concordance = 42.22 to-54.73 g).
CONCLUSION: In patients with HCM, RT3DE demonstrated superior performance than 2DE for the evaluation of myocardial hypertrophy, LV volumes, LVEF, and LV mass.

Entities:  

Mesh:

Year:  2008        PMID: 18445062     DOI: 10.1111/j.1540-8175.2008.00684.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  14 in total

1.  Current clinical applications of transthoracic three-dimensional echocardiography.

Authors:  Luigi P Badano; Francesca Boccalini; Denisa Muraru; Lucia Dal Bianco; Diletta Peluso; Roberto Bellu; Giacomo Zoppellaro; Sabino Iliceto
Journal:  J Cardiovasc Ultrasound       Date:  2012-03-27

2.  Role of echocardiography and cardiac MRI in depicting morphological and functional imaging findings useful for diagnosing hypertrophic cardiomyopathy.

Authors:  A Guarise; N Faccioli; G Foti; S Da Pozzo; P Meneghetti; G Morana
Journal:  Radiol Med       Date:  2010-10-27       Impact factor: 3.469

Review 3.  Imaging of early modification in cardiomyopathy: the doxorubicin-induced model.

Authors:  Mohamed Aissiou; Delphine Périé; Farida Cheriet; Nagib S Dahdah; Caroline Laverdière; Daniel Curnier
Journal:  Int J Cardiovasc Imaging       Date:  2013-06-07       Impact factor: 2.357

4.  Left Ventricular Mid-Diastolic Wall Thickness: Normal Values for Coronary CT Angiography.

Authors:  Jeroen Walpot; Daniel Juneau; Samia Massalha; Girish Dwivedi; Frank J Rybicki; Benjamin J W Chow; João R Inácio
Journal:  Radiol Cardiothorac Imaging       Date:  2019-12-19

5.  A new method to quantify left ventricular mass by 2D echocardiography.

Authors:  Charlotte Burup Kristensen; Katrine Aagaard Myhr; Frederik Fasth Grund; Niels Vejlstrup; Christian Hassager; Raj Mattu; Rasmus Mogelvang
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

Review 6.  Imaging techniques for the assessment of adverse cardiac remodeling in metabolic syndrome.

Authors:  Alberto Preda; Luca Liberale; Fabrizio Montecucco
Journal:  Heart Fail Rev       Date:  2021-11-18       Impact factor: 4.654

7.  Echocardiographic Left Ventricular Mass Estimation: Two-Dimensional Area-Length Method is Superior to M-Mode Linear Method in Swine Models of Cardiac Diseases.

Authors:  Satoshi Miyashita; Nadjib Hammoudi; Shin Watanabe; Olympia Bikou; Kelly Yamada; Jaume Aguero; Koichi Nomoto; Taro Kariya; Kenneth Fish; Roger J Hajjar; Kiyotake Ishikawa
Journal:  J Cardiovasc Transl Res       Date:  2019-12-11       Impact factor: 4.132

Review 8.  Performance of 3-dimensional echocardiography in measuring left ventricular volumes and ejection fraction: a systematic review and meta-analysis.

Authors:  Jennifer L Dorosz; Dennis C Lezotte; David A Weitzenkamp; Larry A Allen; Ernesto E Salcedo
Journal:  J Am Coll Cardiol       Date:  2012-05-15       Impact factor: 24.094

9.  Three-dimensional echocardiography for left ventricular quantification: fundamental validation and clinical applications.

Authors:  J A van der Heide; S A Kleijn; M F A Aly; J Slikkerveer; O Kamp
Journal:  Neth Heart J       Date:  2011-10       Impact factor: 2.380

10.  An initial study on left ventricular diastolic function in patients with hypertrophy cardiomyopathy using single-beat, real-time, three-dimensional echocardiography.

Authors:  Bei Zhao; Juan Li; Yong Xu; Hong-Wei Zhu; Guang Zhi
Journal:  J Geriatr Cardiol       Date:  2012-09       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.